BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co successfully leads a €100.1 million capital increase for Transgene
Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma
Bryan, Garnier & Co leads a 11,5 million IPO for MEDICREA on Alternext
Bryan, Garnier & Co & ING announce the successful completion of BioAlliance Pharma (Eurolist Paris : FR0010095596) EUR 30 m Initial Public Offering
Bryan, Garnier & Co, the European Growth investment bank successfully led the the secondary placement of a EUR 13M holding of 21 Investimenti in Stedim, a Euronext-listed company
Bryan, Garnier & Co Leads a EUR 34,9 M follow-on offering of Ordinary Shares with Warrants (ABSA) from Leading International Institutional Investors for Transgene (Eurolist Paris : FR0005175080)
1
…
16
17
18
Privacy Preference Center
Privacy Preferences